Enclara is in Front of the Hospice Industry Market Changes
West Deptford, NJ (PRWEB) March 25, 2014 -- Enclara Health, a leading hospice provider pharmacy, will be showcasing its services and the innovative tools it has developed to help hospice providers to stay in front of the vast changes taking place in the industry related to recent CMS updates. Visit Booth #302 at the National Hospice and Palliative Care (NHPCO) Management & Leadership Conference taking place at the Gaylord Conference Center in National Harbor, MD from March 25-27th to learn more.
“The two most pressing topics in the industry are the additional reporting requirements brought about by CR 8358 and the recent announcements from CMS restricting Medicare Part D drug coverage for hospice patients. We are offering our existing clients and prospects guidance and support in understanding the impact of these developments,” said Andy Horowitz, CEO of Enclara Health. “We look forward to meeting with the industry and being a part of the conversation at the NHPCO conference. More importantly, we are working collaboratively with our business partners to better understand these changes and the impact they may have on the provision of hospice pharmacy services at the end of life. As part of this effort, we are developing supportive tools and our own workflow changes to help mitigate the impact to our clients.”
Enclara offers clients daily access to information to support the necessary reporting pursuant to CR 8358. Enclara’s CR 8358 reporting tool was launched on March 14, 2014. Customers have the ability to generate a file from Enclara’s system that is able to be imported into the required format for many of the leading EMR vendors’ specified format for CMS submission. At this time, such ability is functional for: Allscripts, Cerner, EPIC, HCHB, McKesson, MUMMS, and Suncoast. Enclara also offers file upload options for those hospices that don’t utilize an EMR.
“Enclara recognizes the importance of working with our customers and their software vendors to ease the reporting burden for the hospice industry,” added Horowitz. To learn more about how Enclara is facilitating the reporting requirements for a hospice, please visit https://29e5d3.campgn4.com/CR-8358-31714.
In addition, Enclara has developed supportive tools to help its customer base deal with the announced Hospice / Medicare Part D changes. Enclara is offering guidance on related / unrelated determinations; safe discontinuation guidelines for inappropriate medications, “drug exposure” reviews, prior authorization assistance, and pricing options, all intended to help our client’s mitigate risk.
The NHPCO Leadership & Management Conference brings together presidents and CEOs, administrators, directors, clinical managers, finance and development managers/coordinators, quality and performance improvement professionals, at all levels of hospice, palliative and the continuum of care.
About Enclara Health Enclara Health supports its hospice partners through cost effective, clinical excellence in both mail order and local pharmacy access. Enclara, established in 2007, is committed to meeting the unique and changing needs of the hospice market and truly demonstrate that there is a difference in hospice pharmacy providers. For more information, visit http://www.enclarahealth.com.
# # #
Amy Riemer, Enclara Health, +1 (978) 475-4441, [email protected]
Share this article